PKC‐δ enhances the HIF‐1α transcriptional activity by increasing the nuclear translocation, and VitK2 suppresses the HIF‐1α activation through the inhibition of PKC in HCC cells. The gene discussed is HIF1A; the disease is hepatocellular carcinoma.